About the Rome IV Criteria for Functional Diarrhoea
Two absences define this disorder, not the diarrhoea itself. Rome IV requires loose or watery stools in more than 25% of stools, occurring over three months with onset at least six months ago — and crucially, *without* predominant abdominal pain and *without* bothersome bloating. Predominant pain makes it diarrhoea-predominant IBS; predominant bloating makes it functional abdominal bloating. Because the diarrhoea itself is unremarkable, everything that matters here is in the exclusions: bile acid diarrhoea, coeliac disease and microscopic colitis all present exactly this way and are all specifically treatable.
Formula
Functional diarrhoea = timing AND (loose/watery stools > 25% of stools) AND no predominant pain or bothersome bloating AND NOT IBS-D- > 25% of stools
- A proportion, not a daily frequency. A patient opening their bowels twice daily with one loose stool meets this; a patient with six formed stools and one loose one does not.
- Predominant
- Rome IV's wording is deliberate. Mild pain or minor bloating does not exclude the diagnosis; pain or bloating that dominates the picture does.
- A single symptom criterion plus exclusions — this is the simplest of the Rome IV bowel disorders.
- The 25% threshold is a proportion of stools, which patients estimate poorly without a diary.
- Mutually exclusive with IBS-D. Rome IV does not permit both labels simultaneously.
- The criteria are silent on organic exclusion beyond IBS, so the work-up for treatable mimics sits outside them and has to be driven by the clinician.
Interpreting the result
Treat a positive result as an instruction to complete the work-up rather than as a conclusion. The three exclusions that matter most are bile acid diarrhoea, coeliac disease and microscopic colitis, and none is reliably caught by routine testing — bile acid diarrhoea needs a SeHCAT scan or a therapeutic trial of a sequestrant, coeliac disease needs serology on a gluten-containing diet, and microscopic colitis needs biopsies from a macroscopically normal colon. Faecal calprotectin helps separate inflammatory from functional disease. Review medications, particularly metformin, magnesium-containing preparations, proton pump inhibitors and artificial sweeteners. Where the criteria are not met, read which one failed: predominant pain routes the patient to IBS-D, and predominant bloating to functional abdominal bloating. If everything is genuinely excluded, loperamide titrated to effect is the mainstay, with bile acid sequestrants worth an empirical trial in patients whose pattern fits even where formal testing is unavailable.
| Score | Band | What it means | Action |
|---|---|---|---|
| All criteria met | Functional diarrhoea | Loose or watery stools in more than a quarter of stools, without predominant pain or bloating, and not meeting IBS-D criteria | Exclude bile acid diarrhoea, coeliac disease and microscopic colitis specifically before settling; then loperamide titrated to effect |
| Predominant abdominal pain | Criteria not met — IBS with diarrhoea | Pain related to defecation makes this IBS-D | Use the Rome IV IBS pathway; the licensed treatments differ |
| Predominant bloating | Criteria not met — assess bloating disorder | Bloating or distension dominating over stool form points elsewhere | Assess for functional abdominal bloating and distension |
What the Functional Diarrhoea needs (4 inputs)
- Timing
- Criteria fulfilled for the last three months with symptom onset at least six months before diagnosis.
- Loose or watery stools in more than 25% of stools
- A proportion of stools rather than a count per day. Bristol types 6 and 7 are the practical anchor, and a stool diary makes the estimate far more reliable than recall.
- Without predominant abdominal pain or bothersome bloating
- The discriminating criterion, and it works in two directions. Predominant pain points to IBS with diarrhoea; predominant bloating points to functional abdominal bloating or distension.
- Criteria for IBS with diarrhoea not met
- Rome IV states this explicitly as an exclusion. The two disorders are mutually exclusive, and the separator is whether abdominal pain is a defining feature.
What it returns
- Criteria met or not met
- All four requirements including the timing rule must hold.
- Which criterion remains outstanding
- Named explicitly, since a failure on the pain or bloating criterion points to a specific alternative disorder rather than to an incomplete assessment.
How it is calculated
Functional diarrhoea is defined negatively, and deliberately so. Rome IV separated it from diarrhoea-predominant IBS on the presence or absence of abdominal pain, because pain is the organising feature of the IBS construct and its absence identifies a group with a different symptom experience and, arguably, different mechanisms — more consistent with accelerated transit and altered bile acid handling than with visceral hypersensitivity. The exclusion of bloating pushes patients whose dominant complaint is distension into a separate category. What remains is loose stool as the primary problem. The underlying mechanisms in that residual group are heterogeneous, which is why the practical emphasis falls so heavily on identifying the subset with a specific treatable cause rather than on the label itself.
Facts & figures
| Condition | How it is found | Why it matters |
|---|---|---|
| Bile acid diarrhoea | SeHCAT, 7αC4, or a therapeutic trial of a sequestrant | Common, frequently missed, responds well to sequestrants |
| Coeliac disease | Serology on a gluten-containing diet, then duodenal biopsies | Presents as painless diarrhoea; treated by diet |
| Microscopic colitis | Biopsies from a macroscopically normal colon | Invisible at colonoscopy; responds to budesonide |
| Inflammatory bowel disease | Faecal calprotectin, then endoscopy | Requires entirely different management |
| Drug-induced | Medication review — metformin, magnesium, PPIs, sweeteners | Free to fix, and routinely overlooked |
| Chronic pancreatitis / exocrine insufficiency | Faecal elastase | Steatorrhoea can be reported simply as loose stool |
Rome IV's criteria say nothing about organic exclusion beyond IBS. That work sits with the clinician, and this list is where the diagnostic yield is.
Evidence
Derivation — Rome Foundation, bowel disorders committee
2016Consensus criteria from the Rome IV bowel disorders committee, published in Gastroenterology in 2016.
Consensus-derived. Rome IV clarified the boundary with IBS-D by specifying the absence of predominant abdominal pain, and added the absence of bothersome bloating to separate it from functional abdominal bloating and distension.
Guideline context — ACG irritable bowel syndrome
2021ACG clinical guideline on the management of irritable bowel syndrome, which addresses the diagnostic separation of IBS-D from functional diarrhoea and the work-up of chronic diarrhoea.
Recommends targeted testing — coeliac serology, faecal calprotectin, and assessment for bile acid diarrhoea — rather than broad investigation in patients with chronic non-bloody diarrhoea without alarm features.
How it compares
Functional Diarrhoea vs IBS with diarrhoea
Mutually exclusive, separated only by whether abdominal pain is predominant — and that boundary is taxonomic rather than mechanistic.
Rome IV requires that functional diarrhoea criteria exclude IBS-D, and the discriminator is recurrent abdominal pain related to defecation or to a change in stool frequency or form. Physiologically the two are hard to separate: bile acid malabsorption occurs in both, transit is accelerated in both, and loperamide helps both. The boundary matters because trials and drug licences follow one definition or the other — several IBS-D drugs are not licensed for functional diarrhoea. In practice, ask about pain explicitly, since a patient whose main complaint is stool frequency will often not mention it.
Functional Diarrhoea vs Bile acid diarrhoea
Not a competing diagnosis but the single most important thing to exclude — it presents identically and has a specific, effective treatment.
Bile acid diarrhoea produces chronic watery diarrhoea without predominant pain, which is to say it meets the functional diarrhoea criteria exactly. It is common, particularly after cholecystectomy, ileal resection or in association with Crohn's disease, and it also occurs idiopathically. Diagnosis is by SeHCAT retention or serum 7αC4 where available, and a therapeutic trial of colestyramine or colesevelam is a reasonable substitute where they are not. Missing it means treating a specifically correctable condition with symptomatic loperamide indefinitely, and it is probably the commonest single reason a functional diarrhoea label is wrong.
Functional Diarrhoea vs Microscopic colitis
Invisible at colonoscopy and diagnosed only on biopsy — so a normal-looking colon without biopsies does not exclude it.
Collagenous and lymphocytic colitis both present with chronic watery non-bloody diarrhoea, typically without predominant pain, in a colon that looks entirely normal endoscopically. They are diagnosed on histology alone, respond to budesonide, and are commoner in older patients and in those on proton pump inhibitors and NSAIDs. The practical rule is to take biopsies from the right and left colon in any patient scoped for chronic diarrhoea regardless of appearance — the alternative is a functional label applied to a treatable inflammatory condition.
Pearls & pitfalls
- Exclude bile acid diarrhoea specifically. It is common, mimics this exactly, and a therapeutic trial of a sequestrant is reasonable where SeHCAT is unavailable.
- Microscopic colitis requires biopsies from a normal-looking colon. A macroscopically normal colonoscopy without biopsies has not excluded it.
- Check coeliac serology on a gluten-containing diet — a patient who has already cut gluten will test falsely negative.
- The 25% threshold is a proportion of stools, not a daily count. A stool diary makes this far more reliable than recall.
- 'Predominant' is doing real work in the pain and bloating criteria. Mild pain does not exclude the diagnosis; dominant pain does.
- Review medications — metformin, magnesium salts, proton pump inhibitors and artificial sweeteners are common and easily reversible causes.
- Nocturnal diarrhoea, weight loss, blood and anaemia are not features of this disorder and require investigation regardless of how well the criteria fit.
- Faecal elastase is worth checking where stools are pale, bulky or difficult to flush — exocrine insufficiency is often reported simply as loose stool.
- Mutually exclusive with IBS-D under Rome IV, so a patient cannot hold both labels.
Critical actions
- Establish whether abdominal pain is predominant — that single question decides between this and IBS with diarrhoea.
- Check coeliac serology on a gluten-containing diet.
- Measure faecal calprotectin to separate inflammatory from functional disease.
- Assess for bile acid diarrhoea by SeHCAT, 7αC4, or a therapeutic trial of a sequestrant.
- Take colonic biopsies at colonoscopy even when the mucosa looks normal, to exclude microscopic colitis.
- Review the drug chart for diarrhoea-inducing agents.
- Investigate rather than reassure where there is nocturnal diarrhoea, blood, weight loss or anaemia.
- Once genuinely excluded, titrate loperamide to effect rather than using it as needed.
Why this score exists
Separating functional diarrhoea from diarrhoea-predominant IBS on the presence of pain is a taxonomic decision the committee made knowingly, and it has the same character as the functional constipation and IBS-C split. The argument for it is that pain is what defines the IBS construct across all its subtypes, so a patient without it is not simply a milder version of the same disorder. The argument against is that patients move between the categories, transit and bile acid measurements do not respect the boundary, and loperamide works in both. What makes this category clinically distinctive is not the label but what it forces you to have ruled out — the committee's own text is thin on organic exclusion, and the practical value of the diagnosis depends almost entirely on the rigour of the work-up preceding it.
About the creator
First author, Rome IV bowel disorders committee
Chaired the committee that produced the Rome IV functional bowel disorder criteria.
Co-author; post-infectious and diarrhoeal bowel disorders
Contributed much of the underlying work on post-infectious and diarrhoea-predominant functional bowel disease.
Limitations
- The criteria say almost nothing about organic exclusion, so the diagnostic rigour depends entirely on the clinician rather than the framework.
- The boundary with IBS-D is taxonomic, and patients migrate across it over time.
- The 25% proportion is estimated by patients unreliably without a stool diary.
- 'Predominant' pain and 'bothersome' bloating are subjective judgements with no anchor.
- Committee-agreed thresholds — the 25% loose-stool figure was chosen for consistency with the rest of the bowel chapter, not shown to separate populations.
- Groups together mechanistically heterogeneous patients — bile acid malabsorption, accelerated transit and post-infectious change all meet the same criteria.
- Says nothing about severity, and patients range from mildly inconvenienced to housebound by urgency.
- Does not address faecal incontinence, which accompanies chronic diarrhoea frequently and is rarely volunteered.
If you are the patient
Functional diarrhoea means loose or watery stools more than a quarter of the time, without tummy pain or bloating being the main problem, and with tests showing no other cause. The 'without pain' part matters — if pain linked to opening your bowels is a leading symptom, the diagnosis is usually irritable bowel syndrome instead, which is managed differently. The most useful thing to know is that several treatable conditions look exactly like this and are easy to miss unless specifically looked for. Bile acid diarrhoea, where the bowel does not reabsorb bile properly, is common and responds well to a specific medicine — it is worth asking whether you have been tested or offered a trial. Coeliac disease is checked with a blood test, but only works if you are still eating gluten, so do not cut it out before testing. Microscopic colitis is a form of inflammation that cannot be seen during a camera test and is only found by taking small tissue samples, so it is worth asking whether biopsies were taken even if the bowel looked normal. It is also worth reviewing your medicines, as several common ones cause loose stools. If all of that is clear, loperamide taken regularly rather than only when things are bad usually gives the best control. Do tell your doctor about diarrhoea that wakes you at night, any blood, or weight loss — those need separate attention.
Frequently asked questions
What are the Rome IV criteria for functional diarrhoea?#
Loose or watery stools in more than 25% of stools, without predominant abdominal pain or bothersome bloating, fulfilled for the last three months with symptom onset at least six months earlier. Patients meeting criteria for diarrhoea-predominant IBS are excluded.
What is the difference between functional diarrhoea and IBS-D?#
Abdominal pain. IBS requires recurrent abdominal pain related to defecation or to a change in stool frequency or form; functional diarrhoea explicitly requires that pain is not predominant and that IBS-D criteria are not met. The two are mutually exclusive under Rome IV, though the boundary is taxonomic and patients move across it over time.
What must be excluded before diagnosing functional diarrhoea?#
Bile acid diarrhoea, coeliac disease, microscopic colitis, inflammatory bowel disease, exocrine pancreatic insufficiency and drug causes. None is reliably caught by routine testing — coeliac serology must be on a gluten-containing diet, microscopic colitis needs biopsies from a normal-looking colon, and bile acid diarrhoea needs SeHCAT or a therapeutic trial.
How common is bile acid diarrhoea in this population?#
Common enough that it should be actively excluded rather than considered only after other options fail. It presents identically to functional diarrhoea, is particularly frequent after cholecystectomy or ileal resection but also occurs idiopathically, and responds well to bile acid sequestrants. It is probably the single commonest reason a functional diarrhoea label turns out to be wrong.
Does the 25% threshold mean stools per day?#
No — it is a proportion of stools, not a daily frequency. More than a quarter of stools must be loose or watery. Patients estimate this poorly from memory, so a one- to two-week stool diary using the Bristol scale makes the assessment considerably more reliable.
Can you have mild pain and still meet the criteria?#
Yes. Rome IV specifies the absence of *predominant* abdominal pain, not the absence of pain altogether. Mild pain accompanying the diarrhoea is compatible with the diagnosis; pain that dominates the clinical picture is not, and moves the patient into the IBS-D category.
How is functional diarrhoea treated?#
Once treatable causes are genuinely excluded, loperamide titrated to effect is the mainstay — taken regularly and dose-adjusted rather than only during flares, which gives better control. A trial of a bile acid sequestrant is reasonable where the pattern fits even without formal testing. Dietary modification and, where relevant, addressing coexisting urgency and incontinence matter as much as the antidiarrhoeal.
Do alarm features change the assessment?#
Yes, and they sit outside the criteria. Nocturnal diarrhoea, rectal bleeding, weight loss, iron deficiency anaemia and a family history of colorectal cancer or coeliac disease all require investigation regardless of how well the Rome IV criteria fit. A functional label must never be used to defer that.
References
Original / primary reference
Clinical practice guidelines
- Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44.
- Chang L, Chey WD, Imdad A, et al. AGA-ACG Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023;164(7):1086-1106 (the companion guideline for the constipated end of the spectrum).